IndraLab

Statements

UCHL1 activates 3',5'-cyclic AMP. 1 / 1

| 1

reach

"Since Uch-L1 enhances the down-stream signaling pathways of cAMP by acting on PKA, this provides another rationale for the targeting of Uch-L1 in SCI treatment."

26858599

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

UCHL1 activates 3',5'-cyclic AMP. 1 / 1

INDRA sources:

Databases

Reading